跳至主要内容
临床试验/NCT05873660
NCT05873660已完成不适用

Multi-centre Cross-sectional Observational Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 5,360 人开始时间: 2023年6月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,360
试验地点
1
主要终点
Overweight and obesity among patients with established CVD pooled across all countries

研究概览

简要总结

The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Adults, age above or equal to 18 years at the time of signing informed consent.
  • Have established CVD and equal to or greater than 1 follow up appointment following an acute event from at least one of the following:
  • Prior myocardial infarction
  • Prior stroke (ischemic or haemorrhagic stroke)
  • Symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease

排除标准

  • Previous participation in this study. Participation is defined as having given informed consent in this study
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
  • Patients with known congenital heart disease/malformation

结局指标

主要结局

Overweight and obesity among patients with established CVD pooled across all countries

时间窗: At the time of patient enrolment (Day 1/Visit 1)

% of patients

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验